文献速递消化道肿瘤与早癌

具核梭杆菌通过激活Toll样受体4信号至核因子-κB并上调微小RNA-21表达促进结直肠癌细胞增殖及小鼠肿瘤发展

Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
PubMed 文献 · Gastroenterology · 2016-11-19

该研究在结直肠癌细胞系和小鼠模型中探讨具核梭杆菌促癌机制。具核梭杆菌通过激活Toll样受体4-MYD88-核因子-κB信号通路上调miR21,抑制RASA1,促进癌细胞增殖、侵袭和移植瘤生长;肿瘤组织具核梭杆菌DNA和miR21高表达患者生存期更短。

要点

  • 具核梭杆菌感染增强结直肠癌细胞增殖、侵袭及裸鼠移植瘤形成能力。
  • 具核梭杆菌经TLR4-MYD88-NF-κB通路上调miR21,进而下调RASA1。
  • 肿瘤组织具核梭杆菌DNA和miR21均高者生存期更短。

核心结论

  • 具核梭杆菌感染可增加结直肠癌细胞增殖、侵袭活性及在小鼠中形成移植瘤的能力。
  • 具核梭杆菌激活Toll样受体4信号至MYD88,导致核因子-κB活化并增加miR21表达;该miRNA降低RAS GTP酶RASA1水平。
  • 组织具核梭杆菌DNA和miR21均高表达的患者不良结局风险更高。

研究设计与样本

  • 体外研究:结直肠癌细胞系与具核梭杆菌或对照试剂共孵育,进行增殖和划痕愈合实验。
  • 动物实验:BALB/C裸鼠注射结直肠癌细胞观察移植瘤生长;C57BL腺瘤性息肉病colimin/+、C57BL miR21a-/-及全长miR21a C57BL对照小鼠经口灌胃具核梭杆菌,部分给予氧化偶氮甲烷和葡聚糖硫酸钠诱导结肠炎和结肠肿瘤。
  • 患者组织分析:中国患者90对肿瘤及匹配非肿瘤组织用于表达相关性分析;日本患者125例肿瘤组织用于与生存时间比较。

主要发现

  • 具核梭杆菌感染的结直肠癌细胞系较对照细胞增殖和侵袭活性增加。
  • 具核梭杆菌感染的结直肠癌细胞在裸鼠中形成的肿瘤更大、更快。
  • 经口灌胃具核梭杆菌的腺瘤性息肉病colimin/+小鼠较PBS组发生显著更多结直肠肿瘤,生存时间更短。
  • 具核梭杆菌小鼠血清中白细胞介素17F、白细胞介素21、白细胞介素22和MIP3A显著升高。
  • 具核梭杆菌与PBS孵育的结直肠癌相比,50个miRNA显著上调、52个miRNA显著下调,miR21升高幅度最大(>4倍)。

关键数值与推荐

  • miR21抑制剂可阻止具核梭杆菌在培养中诱导的细胞增殖和侵袭。
  • miR21a-/-小鼠在给予氧化偶氮甲烷和葡聚糖硫酸钠后,较对照小鼠出现便血和腹泻的时间更晚,生存时间更长。
  • miR21a-/-小鼠结直肠肿瘤更少、体积更小,且生存时间长于对照小鼠。
  • 过表达miR21的细胞中RASA1持续下调,而暴露于miR21抑制剂的细胞中RASA1上调。
  • 患者肿瘤组织(晚期肿瘤组织更明显)中具核梭杆菌DNA和miR21水平高于非肿瘤结肠组织。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Nearly 20% of the global cancer burden can be linked to infectious agents. Fusobacterium nucleatum promotes tumor formation by epithelial cells via unclear mechanisms. We aimed to identify microRNAs (miRNAs) induced by F nucleatum and evaluate their ability to promote colorectal carcinogenesis in mice. METHODS: Colorectal cancer (CRC) cell lines were incubated with F nucleatum or control reagents and analyzed in proliferation and would healing assays. HCT116, HT29, LoVo, and SW480 CRC cell lines were incubated with F nucleatum or phosphate-buffered saline (PBS [control]) and analyzed for miRNA expression patterns and in chromatin immunoprecipitation assays. Cells were incubated with miRNAs mimics, control sequences, or small interfering RNAs; expression of reporter constructs was measured in luciferase assays. CRC cells were incubated with F nucleatum or PBS and injected into BALB/C nude mice; growth of xenograft tumors was measured. C57BL adenomatous polyposis colimin/+, C57BL miR21a-/-, and C57BL mice with full-length miR21a (controls) were given F nucleatum by gavage; some mice were given azoxymethane and dextran sodium sulfate to induce colitis and colon tumors. Intestinal tissues were collected and tumors were counted. Serum samples from mice were analyzed for cytokine levels by enzyme-linked immunosorbent assay. We performed in situ hybridization analyses to detect enrichment of F nucleatum in CRC cells. Fusobacterium nucleatum DNA in 90 tumor and matched nontumor tissues from patients in China were explored for the expression correlation analysis; levels in 125 tumor tissues from patients in Japan were compared with their survival times. RESULTS: Fusobacterium nucleatum increased proliferation and invasive activities of CRC cell lines compared with control cells. CRC cell lines infected with F nucleatum formed larger tumors, more rapidly, in nude mice than uninfected cells. Adenomatous polyposis colimin/+ mice gavaged with F nucleatum developed significantly more colorectal tumors than mice given PBS and had shorter survival times. We found several inflammatory factors to be significantly increased in serum from mice given F nucleatum (interleukin 17F, interleukin 21, and interleukin 22, and MIP3A). We found 50 miRNAs to be significantly up-regulated and 52 miRNAs to be significantly down-regulated in CRCs incubated with F nucleatum vs PBS; levels of miR21 increased by the greatest amount (>4-fold). Inhibitors of miR21 prevented F nucleatum from inducing cell proliferation and invasion in culture. miR21a-/- mice had a later appearance of fecal blood and diarrhea after administration of azoxymethane and dextran sodium sulfate, and had longer survival times compared with control mice. The colorectum of miR21a-/- mice had fewer tumors, of smaller size, and the miR21a-/- mice survived longer than control mice. We found RASA1, which encodes an RAS GTPase, to be one of the target genes consistently down-regulated in cells that overexpressed miR21 and up-regulated in cells exposed to miR21 inhibitors. Infection of cells with F nucleatum increased expression of miR21 by activating Toll-like receptor 4 signaling to MYD88, leading to activation of the nuclear factor-κB. Levels of F nucleatum DNA and miR21 were increased in tumor tissues (and even more so in advanced tumor tissues) compared with non-tumor colon tissues from patients. Patients whose tumors had high amounts of F nucleatum DNA and miR21 had shorter survival times than patients whose tumors had lower amounts. CONCLUSIONS: We found infection of CRC cells with F nucleatum to increase their proliferation, invasive activity, and ability to form xenograft tumors in mice. Fusobacterium nucleatum activates Toll-like receptor 4 signaling to MYD88, leading to activation of the nuclear factor-κB and increased expression of miR21; this miRNA reduces levels of the RAS GTPase RASA1. Patients with both high amount of tissue F nucleatum DNA and miR21 demonstrated a higher risk for poor outcomes.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Yang Y, Weng W, Peng J, et al. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Gastroenterology. 2016. PMID: 27876571. doi:10.1053/j.gastro.2016.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。